ORASURE TECHNOLOGIES INC Logo

ORASURE TECHNOLOGIES INC

Develops and distributes point-of-care diagnostic tests and sample collection devices.

OSUR | NDAQ

Overview

Corporate Details

ISIN(s):
US68554V1089
LEI:
Country:
United States of America
Address:
220 E FIRST ST, 18015 BETHLEHEM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OraSure Technologies, Inc. is a leader in the development, manufacture, and distribution of point-of-care diagnostic tests and sample collection devices. Together with its subsidiaries, including DNA Genotek and Sherlock Biosciences, the company provides innovative solutions for discovering and detecting critical medical conditions. Its product portfolio features rapid diagnostic tests for infectious diseases such as HIV and HCV, as well as sample collection and stabilization technologies. OraSure focuses on improving healthcare access and quality through effortless, often oral fluid-based, testing solutions. The company's products are sold globally to a diverse market, including clinical laboratories, hospitals, public health organizations, government agencies, pharmaceutical companies, and direct to consumers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ORASURE TECHNOLOGIES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ORASURE TECHNOLOGIES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ORASURE TECHNOLOGIES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
United States of America ARWR
ARS Pharmaceuticals, Inc. Logo
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
United States of America SPRY
ARTELO BIOSCIENCES, INC. Logo
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
United States of America ARTL
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America ARTV
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Ascendis Pharma A/S Logo
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
United States of America ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.
United States of America AAPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.